PI-RADS: what is new and how to use it
Abstract The prostate imaging reporting and data system (PI-RADS) has revolutionized the use of magnetic resonance imaging (MRI) for the management of prostate cancer (PCa). The most recent version 2.1, PI-RADS v2.1, provides specific refinements in the performance, relaxing some recommendations which were not found to be helpful, while reinforcing and clarifying others. The interpretation of T2-weighted imaging (T2WI) in the transition zone (TZ), and the overall assessment of TZ nodules, now allows for a clearer distinction between those which are clearly benign and those which might warrant tissue sampling. Additional changes also resolve discrepancies in T2WI and diffusion-weighted imaging (DWI) of the peripheral zone (PZ). PI-RADS v2.1 is a simpler, more straightforward, and more reproducible method to better communicate between physicians regarding findings on prostate MRI..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Abdominal radiology - 45(2020), 12 vom: 17. März, Seite 3951-3960 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dutruel, Silvina P. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
---|
Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2020 |
---|
doi: |
10.1007/s00261-020-02482-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2121670629 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | OLC2121670629 | ||
003 | DE-627 | ||
005 | 20230504185438.0 | ||
007 | tu | ||
008 | 230504s2020 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s00261-020-02482-x |2 doi | |
035 | |a (DE-627)OLC2121670629 | ||
035 | |a (DE-He213)s00261-020-02482-x-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Dutruel, Silvina P. |e verfasserin |0 (orcid)0000-0003-1335-621X |4 aut | |
245 | 1 | 0 | |a PI-RADS: what is new and how to use it |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2020 | ||
520 | |a Abstract The prostate imaging reporting and data system (PI-RADS) has revolutionized the use of magnetic resonance imaging (MRI) for the management of prostate cancer (PCa). The most recent version 2.1, PI-RADS v2.1, provides specific refinements in the performance, relaxing some recommendations which were not found to be helpful, while reinforcing and clarifying others. The interpretation of T2-weighted imaging (T2WI) in the transition zone (TZ), and the overall assessment of TZ nodules, now allows for a clearer distinction between those which are clearly benign and those which might warrant tissue sampling. Additional changes also resolve discrepancies in T2WI and diffusion-weighted imaging (DWI) of the peripheral zone (PZ). PI-RADS v2.1 is a simpler, more straightforward, and more reproducible method to better communicate between physicians regarding findings on prostate MRI. | ||
650 | 4 | |a Prostate | |
650 | 4 | |a Cancer | |
650 | 4 | |a MRI | |
650 | 4 | |a PI-RADS | |
650 | 4 | |a Assessment | |
650 | 4 | |a Reporting | |
700 | 1 | |a Jeph, Sunil |0 (orcid)0000-0002-8403-6814 |4 aut | |
700 | 1 | |a Margolis, Daniel J. A. |0 (orcid)0000-0001-8212-707X |4 aut | |
700 | 1 | |a Wehrli, Natasha |0 (orcid)0000-0002-6962-9005 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Abdominal radiology |d Springer US, 2016 |g 45(2020), 12 vom: 17. März, Seite 3951-3960 |w (DE-627)840011903 |w (DE-600)2839786-1 |w (DE-576)451643356 |x 2366-004X |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2020 |g number:12 |g day:17 |g month:03 |g pages:3951-3960 |
856 | 4 | 1 | |u https://doi.org/10.1007/s00261-020-02482-x |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
951 | |a AR | ||
952 | |d 45 |j 2020 |e 12 |b 17 |c 03 |h 3951-3960 |